These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Okarvi SM; Al Jammaz I Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867 [TBL] [Abstract][Full Text] [Related]
5. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
6. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010 [TBL] [Abstract][Full Text] [Related]
7. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677 [TBL] [Abstract][Full Text] [Related]
8. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties. Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571 [TBL] [Abstract][Full Text] [Related]
10. Co-administration of succinylated gelatine with a (99m)Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake. Liolios CC; Xanthopoulos S; Loudos G; Varvarigou AD; Sivolapenko GB Nucl Med Biol; 2016 Oct; 43(10):625-34. PubMed ID: 27497631 [TBL] [Abstract][Full Text] [Related]
11. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models. Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957 [TBL] [Abstract][Full Text] [Related]
12. Development and Preclinical Evaluation of Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303 [TBL] [Abstract][Full Text] [Related]
13. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Smith CJ; Gali H; Sieckman GL; Higginbotham C; Volkert WA; Hoffman TJ Bioconjug Chem; 2003; 14(1):93-102. PubMed ID: 12526698 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent. Okarvi SM; al-Jammaz I Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569 [TBL] [Abstract][Full Text] [Related]
15. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives. Fragogeorgi EA; Zikos C; Gourni E; Bouziotis P; Paravatou-Petsotas M; Loudos G; Mitsokapas N; Xanthopoulos S; Mavri-Vavayanni M; Livaniou E; Varvarigou AD; Archimandritis SC Bioconjug Chem; 2009 May; 20(5):856-67. PubMed ID: 19344122 [TBL] [Abstract][Full Text] [Related]
16. New Gastrin Releasing Peptide Receptor-Directed [ Nock BA; Charalambidis D; Sallegger W; Waser B; Mansi R; Nicolas GP; Ketani E; Nikolopoulou A; Fani M; Reubi JC; Maina T J Med Chem; 2018 Apr; 61(7):3138-3150. PubMed ID: 29517903 [TBL] [Abstract][Full Text] [Related]
17. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. Maina T; Nock BA; Zhang H; Nikolopoulou A; Waser B; Reubi JC; Maecke HR J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357 [TBL] [Abstract][Full Text] [Related]
18. Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26. Mitran B; Varasteh Z; Selvaraju RK; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Rosenström U; Orlova A Int J Oncol; 2016 May; 48(5):2124-34. PubMed ID: 26983776 [TBL] [Abstract][Full Text] [Related]